BRTX
Price
$1.43
Change
-$0.02 (-1.38%)
Updated
Sep 26 closing price
Capitalization
11.41M
52 days until earnings call
CERO
Price
$5.39
Change
+$0.01 (+0.19%)
Updated
Sep 26 closing price
Capitalization
6.5M
Interact to see
Advertisement

BRTX vs CERO

Header iconBRTX vs CERO Comparison
Open Charts BRTX vs CEROBanner chart's image
BioRestorative Therapies
Price$1.43
Change-$0.02 (-1.38%)
Volume$170.73K
Capitalization11.41M
CERO Therapeutics Holdings
Price$5.39
Change+$0.01 (+0.19%)
Volume$296.52K
Capitalization6.5M
BRTX vs CERO Comparison Chart in %
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. CERO commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Buy and CERO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BRTX: $1.43 vs. CERO: $5.39)
Brand notoriety: BRTX and CERO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 227% vs. CERO: 175%
Market capitalization -- BRTX: $11.41M vs. CERO: $6.5M
BRTX [@Biotechnology] is valued at $11.41M. CERO’s [@Biotechnology] market capitalization is $6.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 1 FA rating(s) are green whileCERO’s FA Score has 1 green FA rating(s).

  • BRTX’s FA Score: 1 green, 4 red.
  • CERO’s FA Score: 1 green, 4 red.
According to our system of comparison, both BRTX and CERO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 3 TA indicator(s) are bullish while CERO’s TA Score has 4 bullish TA indicator(s).

  • BRTX’s TA Score: 3 bullish, 7 bearish.
  • CERO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CERO is a better buy in the short-term than BRTX.

Price Growth

BRTX (@Biotechnology) experienced а -1.38% price change this week, while CERO (@Biotechnology) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

BRTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRTX($11.4M) has a higher market cap than CERO($6.5M). BRTX YTD gains are higher at: 0.000 vs. CERO (-95.508). BRTX has more cash in the bank: 7.38M vs. CERO (3.8M). BRTX has less debt than CERO: BRTX (42.4K) vs CERO (1.15M).
BRTXCEROBRTX / CERO
Capitalization11.4M6.5M175%
EBITDA-12.89MN/A-
Gain YTD0.000-95.508-
P/E RatioN/AN/A-
Revenue605KN/A-
Total Cash7.38M3.8M194%
Total Debt42.4K1.15M4%
FUNDAMENTALS RATINGS
BRTX: Fundamental Ratings
BRTX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRTXCERO
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
14%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
43%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
29%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 30 days ago
86%
Bullish Trend 12 days ago
56%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUBI67.450.62
+0.93%
Customers Bancorp
BTMD2.990.02
+0.67%
Biote Corp
CHNR4.90N/A
N/A
China Natural Resources Inc
BCYC7.40-0.14
-1.86%
Bicycle Therapeutics plc
ONON42.47-1.45
-3.30%
On Holding AG

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with SBMFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then SBMFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
-1.38%
SBMFF - BRTX
35%
Loosely correlated
N/A
RNA - BRTX
33%
Poorly correlated
+5.17%
CERO - BRTX
29%
Poorly correlated
+0.19%
RLAY - BRTX
29%
Poorly correlated
+18.04%
VRNA - BRTX
28%
Poorly correlated
N/A
More

CERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERO has been loosely correlated with CBIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CERO jumps, then CBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
+0.19%
CBIO - CERO
47%
Loosely correlated
+0.16%
UNCY - CERO
37%
Loosely correlated
+7.49%
UTHR - CERO
33%
Loosely correlated
+1.70%
ACXP - CERO
32%
Poorly correlated
+0.75%
IBIO - CERO
30%
Poorly correlated
+1.79%
More